[HTML][HTML] Non-coding RNAs as biomarkers and therapeutic targets for diabetic kidney disease

YY Gu, FH Lu, XR Huang, L Zhang, W Mao… - Frontiers in …, 2021 - frontiersin.org
Diabetic kidney disease (DKD) is the most common diabetic complication and is a leading
cause of end-stage kidney disease. Increasing evidence shows that DKD is regulated not …

Noncoding RNAs in diabetic nephropathy: pathogenesis, biomarkers, and therapy

J Lv, Y Wu, Y Mai, S Bu - Journal of diabetes research, 2020 - Wiley Online Library
The correlation between diabetes and systematic well‐being on human life has long
established. As a common complication of diabetes, the prevalence of diabetic nephropathy …

[HTML][HTML] Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis

G Garmaa, R Nagy, T Kói, UND To, D Gergő, D Kleiner… - BMC nephrology, 2024 - Springer
Background Accurate detection of kidney damage is key to preventing renal failure, and
identifying biomarkers is essential for this purpose. We aimed to assess the accuracy of …

[HTML][HTML] Roles of microRNA-192 in diabetic nephropathy: the clinical applications and mechanisms of action

X Wan, J Liao, H Lai, S Zhang, J Cui… - Frontiers in …, 2023 - frontiersin.org
Diabetic nephropathy (DN) is one of the most common and intractable microvascular
complications of diabetes worldwide, serving as the main cause of terminal renal disease …

[HTML][HTML] Mi-RNA-93 and mi-RNA-152 in the diagnosis of type 2 diabetes and diabetic retinopathy

AA Saleh, SM El-Hefnawy… - British Journal of …, 2022 - frontierspartnerships.org
Background and Aim: Diabetes mellitus (DM) is a chronic disorder with diabetic retinopathy
(DR) as one of its main microvascular outcomes, being a prime cause of vision loss …

[HTML][HTML] MicroRNAs as potential biomarkers for the diagnosis of chronic kidney disease: a systematic review and meta-analysis

J Li, L Ma, H Yu, Y Yao, Z Xu, W Lin, L Wang… - Frontiers in …, 2022 - frontiersin.org
For Chronic Kidney Disease (CKD), the study of microRNA as a biomarker has become an
exciting area, so we carried out a meta-analysis to investigate the potential diagnostic …

Understanding the Roles of Non-coding RNAs and Exosomal Non-Coding RNAs in Diabetic Nephropathy

Y Zhu, C Liu, J Hallajzadeh - Current Molecular Medicine, 2024 - ingentaconnect.com
One of the greatest serious side effects of diabetes is diabetic nephropathy (DN), which is
also the key factor in the sometimes-deadly diabetic end-stage renal disease. Progressive …

Efficacy of restricting dietary protein intake combined with buyang Huanwu decoction in treating diabetic nephropathy and its effect on patients' inflammatory factor …

D Chen, D Huang, T Hu, F Chen - … ‐Based Complementary and …, 2021 - Wiley Online Library
Objective. To study the efficacy of restricting dietary protein intake combined with Buyang
Huanwu decoction in treating diabetic nephropathy (DN) and its effect on patients' …

Clinical value of miR-23a-3p expression in early diagnosis of diabetic kidney disease

X Meng, X Yu, P Lei - Endokrynologia Polska, 2023 - journals.viamedica.pl
Introduction: The objective was to observe the expression o fm i R-2 3 a-3 p in the serum of
patients with type 2 diabetic nephropathy (T2DN) and to explore its clinical significance …

[HTML][HTML] Troxerutin affects nephropathy signaling events in the kidney of type-1 diabetic male rats

R Keyhanmanesh, G Hamidian, H Lotfi… - Avicenna Journal of …, 2022 - ncbi.nlm.nih.gov
Objective: Nephropathy is known to be the leading cause of kidney failure in diabetic
patients. Troxerutin, as a flavonoid component, could provide a novel protective strategy in …